Metraipolis › archive › dc_4a6288e290dc

Efficacy and Safety of Avatrombopag Treatment in Immune Thrombocytopenia Patients in Poland: A Multicenter Study — Europe PMC PMID:42440844

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42440844
DOI
10.1055/a-2868-3290
License (as archived)
solo-consultazione
Archived
2026-11-02T10:46:41.766Z
SHA-256 of the archived text
4a2c8bccb3bb90c8e546b8ea3d492bc6ff86dd23d690d5379ee753de97bd88e7
Stable URL of this page
https://metraipolis.com/documento/dc_4a6288e290dc

How to cite

Efficacy and Safety of Avatrombopag Treatment in Immune Thrombocytopenia Patients in Poland: A Multicenter Study — Europe PMC PMID:42440844 — Europe PMC (en), https://europepmc.org/article/MED/42440844 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a6288e290dc (Metraipolis archive dc_4a6288e290dc, sha256 4a2c8bccb3bb90c8e546b8ea3d492bc6ff86dd23d690d5379ee753de97bd88e7)
BibTeX
@misc{dc4a6288e290dc,
  title = {Efficacy and Safety of Avatrombopag Treatment in Immune Thrombocytopenia Patients in Poland: A Multicenter Study — Europe PMC PMID:42440844},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42440844},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a6288e290dc; sha256 4a2c8bccb3bb90c8e546b8ea3d492bc6ff86dd23d690d5379ee753de97bd88e7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42440844. Agents can read the archived copy with the MCP tool read_document.